Loading...
INDEX: NASDAQ
SYMBOL: ARQL
NAME: ArQule, Inc.
UPVOTES: 81
DOWNVOTES: 78


Description

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug candidates, all of which are in targeted patient populations. The Company's lead product candidate is tivantinib (ARQ 197), an orally administered, small molecule inhibitor of the c-Met receptor tyrosine kinase (MET) and its biological pathway. The Company's product candidates include ARQ 092, designed to inhibit the AKT serine/threonine kinase; ARQ 087, a multi-kinase inhibitor designed to inhibit the fibroblast growth factor receptor (FGFR) family, and ARQ 761, a Beta lapachone analog being evaluated in investigator-sponsored testing as a promoter of NQO1-mediated programmed cancer cell necrosis.

Read Full Descript at Reuters

ARQL Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
AMDA10
AREX10
LLNW10
ARRY10
A10
NUAN10
SEDG10
AND10
F10
AMRS10
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106
Stock SymbolUp VotesDown VotesVote
COF51
XRX51
NYSE:LMT73
NUAN30
AMFL41
AC42
AUMN31
UNXL31
LLNW31
KNSC31
Stock SymbolUp VotesDown VotesVote
COF179
PULM147
82
ABBV115
AUMN105
MIK94
MNGA83
DFS127
ASTI105
ENDRQ61
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106

Last 10 Stocks Voted On

Stock SymbolActionVote
APAFFDOWNVOTE
VKTXDOWNVOTE
DRYSDOWNVOTE
SEDGUPVOTE
AMDAUPVOTE
AGRXDOWNVOTE
ACOLDOWNVOTE
ANDUPVOTE
AREXUPVOTE
AIDOWNVOTE